![Table 3 from Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar Table 3 from Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/66b1cd66c5a66439bb3847578e78918661a4df89/4-Table3-1.png)
Table 3 from Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar
![Comparison of the Normal CA 19-9 Level Group and Elevated CA 19-9 Level... | Download Scientific Diagram Comparison of the Normal CA 19-9 Level Group and Elevated CA 19-9 Level... | Download Scientific Diagram](https://www.researchgate.net/publication/236100822/figure/tbl2/AS:202838136365068@1425371788588/Comparison-of-the-Normal-CA-19-9-Level-Group-and-Elevated-CA-19-9-Level-Group.png)
Comparison of the Normal CA 19-9 Level Group and Elevated CA 19-9 Level... | Download Scientific Diagram
![Patients with normal‑range CA19‑9 levels represent a distinct subgroup of pancreatic cancer patients Patients with normal‑range CA19‑9 levels represent a distinct subgroup of pancreatic cancer patients](https://www.spandidos-publications.com/article_images/ol/13/2/ol-13-02-0881-g00.jpg)
Patients with normal‑range CA19‑9 levels represent a distinct subgroup of pancreatic cancer patients
![Frontiers | Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy Frontiers | Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy](https://www.frontiersin.org/files/Articles/52319/fonc-03-00155-HTML/image_m/fonc-03-00155-t001.jpg)
Frontiers | Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy
![CA 19-9 level in different T stages, grades, depth of invasion, and in... | Download Scientific Diagram CA 19-9 level in different T stages, grades, depth of invasion, and in... | Download Scientific Diagram](https://www.researchgate.net/publication/225044947/figure/tbl1/AS:202694657613824@1425337580006/CA-19-9-level-in-different-T-stages-grades-depth-of-invasion-and-in-metastatic.png)
CA 19-9 level in different T stages, grades, depth of invasion, and in... | Download Scientific Diagram
![Cancers | Free Full-Text | Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer Cancers | Free Full-Text | Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer](https://www.mdpi.com/cancers/cancers-13-04224/article_deploy/html/images/cancers-13-04224-g001.png)
Cancers | Free Full-Text | Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer
![Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study | World Journal of Surgical Oncology | Full Text Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study | World Journal of Surgical Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1477-7819-12-171/MediaObjects/12957_2013_Article_1666_Fig2_HTML.jpg)
Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study | World Journal of Surgical Oncology | Full Text
![The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer—a report of two cases - Al-Shamsi - Journal of Gastrointestinal The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer—a report of two cases - Al-Shamsi - Journal of Gastrointestinal](https://cdn.amegroups.cn/journals/pbpc/files/journals/1/articles/6877/public/6877-PB8-R1.png/w300)
The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer—a report of two cases - Al-Shamsi - Journal of Gastrointestinal
![Nutrients | Free Full-Text | The Association of Carbohydrate Antigen (CA) 19-9 Levels and Low Skeletal Muscle Mass in Healthy Adults Nutrients | Free Full-Text | The Association of Carbohydrate Antigen (CA) 19-9 Levels and Low Skeletal Muscle Mass in Healthy Adults](https://www.mdpi.com/nutrients/nutrients-15-03394/article_deploy/html/images/nutrients-15-03394-g001.png)
Nutrients | Free Full-Text | The Association of Carbohydrate Antigen (CA) 19-9 Levels and Low Skeletal Muscle Mass in Healthy Adults
![Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies](http://www.tropicalgastro.com/uploads/Untitlemscd-31.jpg)
Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
![How do we interpret an elevated carbohydrate antigen 19-9 level in asymptomatic subjects? - ScienceDirect How do we interpret an elevated carbohydrate antigen 19-9 level in asymptomatic subjects? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1590865808008566-gr1.jpg)
How do we interpret an elevated carbohydrate antigen 19-9 level in asymptomatic subjects? - ScienceDirect
![Frontiers | Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy Frontiers | Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy](https://www.frontiersin.org/files/Articles/52319/fonc-03-00155-HTML/image_m/fonc-03-00155-g003.jpg)
Frontiers | Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy
![Comparison of the Normal CA 19-9 Level Group and Elevated CA 19-9 Level... | Download Scientific Diagram Comparison of the Normal CA 19-9 Level Group and Elevated CA 19-9 Level... | Download Scientific Diagram](https://www.researchgate.net/profile/Seung-Woo-Park-2/publication/236100822/figure/tbl2/AS:202838136365068@1425371788588/Comparison-of-the-Normal-CA-19-9-Level-Group-and-Elevated-CA-19-9-Level-Group_Q320.jpg)
Comparison of the Normal CA 19-9 Level Group and Elevated CA 19-9 Level... | Download Scientific Diagram
![Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-65720-8/MediaObjects/41598_2020_65720_Fig1_HTML.png)
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
![Table 1 from Causes of Elevated Levels of Serum CA 19.9 in Patients without Prior Diagnosis of Malignant Disease | Semantic Scholar Table 1 from Causes of Elevated Levels of Serum CA 19.9 in Patients without Prior Diagnosis of Malignant Disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/74c3ee266306e329e455ec503fd8a28d53a52caa/2-Table1-1.png)
Table 1 from Causes of Elevated Levels of Serum CA 19.9 in Patients without Prior Diagnosis of Malignant Disease | Semantic Scholar
Clinical Significance and Revisiting the Meaning of CA 19-9 Blood Level Before and After the Treatment of Pancreatic Ductal Adenocarcinoma: Analysis of 1,446 Patients from the Pancreatic Cancer Cohort in a Single
![Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies](http://www.tropicalgastro.com/uploads/Untitlnkged-30.jpg)
Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
![CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/2001025641/2003896921/gr1.gif)